You are viewing an incomplete version of our website. Please click to reload the website as full version.

Survivin antibody (BIRC5) (Nuclear)

Details for Product anti-BIRC5 Antibody No. ABIN153037, Supplier: Log in to see
Antigen
  • AAC-11
  • api4
  • Api4
  • BIR1
  • bir5a
  • birc5
  • BIRC5
  • epr-1
  • LOC398389
  • SIX
  • Su1
  • Su2
  • Survivin
  • survivin
  • Survivin1
  • survivin40
  • svv1
  • svv2
  • TIAP
  • XBIR1
  • xsurv
  • xSurvivin
  • xSurvivin1
  • xSurvivin2
Epitope
Nuclear
65
21
21
15
14
14
14
14
11
6
6
6
5
5
4
4
3
3
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
Reactivity
Hamster, Human
355
129
127
23
15
15
8
1
1
1
Host
Mouse
251
110
17
1
Clonality (Clone)
Monoclonal ()
Conjugate
This Survivin antibody is un-conjugated
16
14
11
11
8
8
8
6
6
6
6
6
4
3
3
3
3
3
2
2
2
2
2
2
1
1
1
Application
Immunocytochemistry (ICC), Immunofluorescence (IF), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p)), Immunoprecipitation (IP), Immunohistochemistry (IHC), ELISA, Western Blotting (WB)
290
145
126
121
116
108
53
43
24
11
11
11
10
9
6
2
2
2
2
1
1
Supplier
Log in to see
Supplier Product No.
Log in to see
Request

Get this product for free

It's quick and easy to submit your validation proposal. I want to validate this product

Learn more

Available images

Immunogen Full length recombinant human Survivin [UniProt# O15392]
Clone 32-1
Isotype IgG1 kappa
Specificity This antibody is specific for the nuclear form of survivin.
Purification Protein G purified
Alternative Name Survivin (BIRC5 Antibody Abstract)
Background Gene Symbol: BIRC5
Molecular Weight Theoretical MW: 16.5 kDa
UniProt O15392
Research Area Neurology, Apoptosis/Necrosis, Glia marker, Cancer
Application Notes Western Blot 1:1000, ELISA, Immunohistochemistry 20 μg/mL, Immunocytochemistry/Immunofluorescence 1:10-1:500, Immunoprecipitation, Immunohistochemistry-Paraffin 20 μg/mL
Comment

The antibodies are intended for use in vitro experiments only. Our antibodies have not been tested nor are recommended for use in vivo.

Protocol Protocol specific for Survivin Antibody IHC-FFPE sections I. Deparaffinization:A. Treat slides with Xylene: 3 changes for 5 minutes each. Drain slides for 10 seconds between changes. B. Treat slides with 100 % Reagent Alcohol: 3 changes for 5 minutes each. Drain slides for 10 seconds between changes. II. Quench Endogenous Peroxidase: A. Place slides in peroxidase quenching solution: 15-30 minutes. To Prepare 200 mL of Quenching Solution: Add 3 mL of 30 % Hydrogen Peroxide to 200 mL of Methanol. Use within 4 hours of preparation B. Place slides in distilled water: 2 changes for 2 minutes each. III. Retrieve Epitopes: A. Preheat Citrate
Restrictions For Research Use only
Format Liquid
Concentration 1.9 mg/mL
Buffer PBS
Buffer contains: 0.02 % Sodium Azide
Preservative Sodium azide
Precaution of Use This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Handling Advice Avoid freeze-thaw cycles
Storage -20 °C,-80 °C
Storage Comment Aliquot and store at -20°C or -80°C. Avoid freeze-thaw cycles.
Supplier Images
Immunohistochemistry (IHC) image for anti-Survivin antibody (BIRC5) (Nuclear) (ABIN153037) Staining of human lung, cancer using ABIN153037.
Product cited in: Guvenc, Pavlyukov, Joshi, Kurt, Banasavadi-Siddegowda, Mao, Hong, Yamada, Kwon, Bhasin, Chettiar, Kitange, Park, Sarkaria, Li, Shakhparonov, Nakano: "Impairment of glioma stem cell survival and growth by a novel inhibitor for Survivin-Ran protein complex." in: Clinical cancer research : an official journal of the American Association for Cancer Research, Vol. 19, Issue 3, pp. 631-42, 2013 (PubMed). (Sample species: Human). Further details: Immunoprecipitation

Hori, Miki, Okamoto, Yazama, Konishi, Kaneko, Shimamoto, Ota, Temme, Tatsuka: "The detergent-soluble cytoplasmic pool of survivin suppresses anoikis and its expression is associated with metastatic disease of human colon cancer." in: PLoS ONE, Vol. 8, Issue 2, pp. e55710, 2013 (PubMed). Further details: Western Blotting

Lechler, Renkawitz, Campean, Balakrishnan, Tingart, Grifka, Schaumburger: "The antiapoptotic gene survivin is highly expressed in human chondrosarcoma and promotes drug resistance in chondrosarcoma cells in vitro." in: BMC cancer, Vol. 11, pp. 120, 2011 (PubMed).

Lechler, Schaumburger, Köck, Balakrishnan, Doukas, Prantl, Grifka: "The oncofetal gene survivin promotes cell proliferation and survival in primary human osteoblastic cells." in: Calcified tissue international, Vol. 89, Issue 3, pp. 211-20, 2011 (PubMed). (Sample species: Human). Further details: Immunocytochemistry,Immunofluorescence

Qi, Tuncel, Aoki, Tanaka, Oka, Kaneko, Okamoto, Tatsuka, Nakai, Shimamoto: "Intracellular localization of survivin determines biological behavior in colorectal cancer." in: Oncology reports, Vol. 22, Issue 3, pp. 557-62, 2009 (PubMed). (Sample species: Human). Further details: Western Blotting,Immunohistochemistry

Lechler, Wu, Bernhardt, Campean, Gastiger, Hackenbeck, Klanke, Weidemann, Warnecke, Amann, Engehausen, Willam, Eckardt, Rödel, Wiesener: "The tumor gene survivin is highly expressed in adult renal tubular cells: implications for a pathophysiological role in the kidney." in: The American journal of pathology, Vol. 171, Issue 5, pp. 1483-98, 2007 (PubMed). Further details: Immunohistochemistry (Paraffin-embedded Sections)

Ding, Prieto, Zhang, Rosenthal, Smith, Skelton, Diwan: "Nuclear expression of the antiapoptotic protein survivin in malignant melanoma." in: Cancer, Vol. 106, Issue 5, pp. 1123-9, 2006 (PubMed). (Sample species: Human). Further details: Immunohistochemistry (Paraffin-embedded Sections)

Giodini, Kallio, Wall, Gorbsky, Tognin, Marchisio, Symons, Altieri: "Regulation of microtubule stability and mitotic progression by survivin." in: Cancer research, Vol. 62, Issue 9, pp. 2462-7, 2002 (PubMed).

Fortugno, Wall, Giodini, OConnor, Plescia, Padgett, Tognin, Marchisio, Altieri: "Survivin exists in immunochemically distinct subcellular pools and is involved in spindle microtubule function." in: Journal of cell science, Vol. 115, Issue Pt 3, pp. 575-85, 2002 (PubMed). (Sample species: Human). Further details: Immunocytochemistry,Western Blotting,Immunoprecipitation,ELISA,Immunofluorescence

Adida, Haioun, Gaulard, Lepage, Morel, Briere, Dombret, Reyes, Diebold, Gisselbrecht, Salles, Altieri, Molina: "Prognostic significance of survivin expression in diffuse large B-cell lymphomas." in: Blood, Vol. 96, Issue 5, pp. 1921-5, 2000 (PubMed).

Grossman, McNiff, Li, Altieri: "Expression and targeting of the apoptosis inhibitor, survivin, in human melanoma." in: The Journal of investigative dermatology, Vol. 113, Issue 6, pp. 1076-81, 2000 (PubMed).

Li, Ackermann, Bennett, Rothermel, Plescia, Tognin, Villa, Marchisio, Altieri: "Pleiotropic cell-division defects and apoptosis induced by interference with survivin function." in: Nature cell biology, Vol. 1, Issue 8, pp. 461-6, 2000 (PubMed).

Background publications Li, Ambrosini, Chu, Plescia, Tognin, Marchisio, Altieri: "Control of apoptosis and mitotic spindle checkpoint by survivin." in: Nature, Vol. 396, Issue 6711, pp. 580-4, 1999 (PubMed).

Ambrosini, Adida, Sirugo, Altieri: "Induction of apoptosis and inhibition of cell proliferation by survivin gene targeting." in: The Journal of biological chemistry, Vol. 273, Issue 18, pp. 11177-82, 1998 (PubMed).